Waldencast PLC (NASDAQ:WALD – Get Free Report) was the target of a large decline in short interest during the month of August. As of August 14th, there was short interest totaling 58,897 shares, a decline of 79.2% from the July 30th total of 282,629 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 225,077 shares, the short-interest ratio is presently 0.3 days.
Wall Street Analyst Weigh In
Several analysts have issued reports on the company. Weiss Ratings raised Waldencast from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 17th. Canaccord Genuity Group boosted their price target on Waldencast from $2.00 to $3.00 and gave the stock a “buy” rating in a report on Tuesday, June 2nd. Finally, Wall Street Zen raised shares of Waldencast to a “hold” rating in a report on Saturday, May 30th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $2.33.
View Our Latest Stock Analysis on WALD
Institutional Trading of Waldencast
Waldencast Trading Up 2.3%
Shares of WALD opened at $1.36 on Wednesday. The company has a quick ratio of 0.97, a current ratio of 1.70 and a debt-to-equity ratio of 0.29. The company has a 50 day moving average price of $1.58 and a 200-day moving average price of $1.47. Waldencast has a fifty-two week low of $0.72 and a fifty-two week high of $3.22.
Waldencast Company Profile
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners.
Read More
- Five stocks we like better than Waldencast
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.
